Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cystic fibrosis microbiome:

The cystic fibrosis lung microbiome. Surette MG et al. Ann Am Thorac Soc. (2014)

The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis. Green H et al. Semin Respir Crit Care Med. (2015)

Emerging cystic fibrosis pathogens and the microbiome. Mahenthiralingam E et al. Paediatr Respir Rev. (2014)

Search results

Items: 1 to 20 of 345

1.

Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.

Caverly LJ, LiPuma JJ.

Expert Rev Respir Med. 2018 Aug 17. doi: 10.1080/17476348.2018.1513331. [Epub ahead of print]

PMID:
30118374
2.

Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data.

Więcek S, Chudek J, Woś H, Bożentowicz-Wikarek M, Kordys-Darmolinska B, Grzybowska-Chlebowczyk U.

Dis Markers. 2018 Jul 12;2018:5940893. doi: 10.1155/2018/5940893. eCollection 2018.

3.

Staphylococcus aureus in cystic fibrosis: pivotal role or bit part actor?

Hurley MN, Smyth AR.

Curr Opin Pulm Med. 2018 Aug 14. doi: 10.1097/MCP.0000000000000518. [Epub ahead of print]

PMID:
30113336
4.

Next generation microbiology and cystic fibrosis diagnostics: are we there yet?

Moser C, Thomsen TR, Høiby N.

Curr Opin Pulm Med. 2018 Jul 31. doi: 10.1097/MCP.0000000000000516. [Epub ahead of print]

PMID:
30074508
5.

Nontuberculous Mycobacteria in Cystic Fibrosis.

Furukawa BS, Flume PA.

Semin Respir Crit Care Med. 2018 Jun;39(3):383-391. doi: 10.1055/s-0038-1651495. Epub 2018 Aug 2.

PMID:
30071553
6.

Animal models for cystic fibrosis liver disease (CFLD).

Fiorotto R, Amenduni M, Mariotti V, Cadamuro M, Fabris L, Spirli C, Strazzabosco M.

Biochim Biophys Acta. 2018 Jul 30. pii: S0925-4439(18)30275-8. doi: 10.1016/j.bbadis.2018.07.026. [Epub ahead of print] Review.

PMID:
30071276
7.

The pulmonary microbiome: challenges of a new paradigm.

Costa AN, Costa FMD, Campos SV, Salles RK, Athanazio RA.

J Bras Pneumol. 2018 Jul 30:0. doi: 10.1590/S1806-37562017000000209. [Epub ahead of print] English, Portuguese.

8.

Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases.

van der Does AM, Amatngalim GD, Keijser B, Hiemstra PS, Villenave R.

Vaccines (Basel). 2018 Jul 28;6(3). pii: E49. doi: 10.3390/vaccines6030049. Review.

9.

How low can we go? The implications of low bacterial load in respiratory microbiota studies.

Marsh RL, Nelson MT, Pope CE, Leach AJ, Hoffman LR, Chang AB, Smith-Vaughan HC.

Pneumonia (Nathan). 2018 Jul 5;10:7. doi: 10.1186/s41479-018-0051-8. eCollection 2018. Review.

10.

Reevaluating approaches to cystic fibrosis pulmonary exacerbations.

Schechter MS.

Pediatr Pulmonol. 2018 Jul 6. doi: 10.1002/ppul.24125. [Epub ahead of print] Review.

PMID:
29979495
11.

Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis.

de Freitas MB, Moreira EAM, Tomio C, Moreno YMF, Daltoe FP, Barbosa E, Ludwig Neto N, Buccigrossi V, Guarino A.

PLoS One. 2018 Jun 22;13(6):e0198457. doi: 10.1371/journal.pone.0198457. eCollection 2018.

12.

Aspergillus fumigatus Inhibits Pseudomonas aeruginosa in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the CF Airway.

Reece E, Doyle S, Greally P, Renwick J, McClean S.

Front Microbiol. 2018 Jun 5;9:1205. doi: 10.3389/fmicb.2018.01205. eCollection 2018.

13.

Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity.

Hahn A, Bendall ML, Gibson KM, Chaney H, Sami I, Perez GF, Koumbourlis AC, McCaffrey TA, Freishtat RJ, Crandall KA.

Front Microbiol. 2018 May 25;9:1069. doi: 10.3389/fmicb.2018.01069. eCollection 2018.

14.

Culture-independent Analysis of Pediatric Broncho-alveolar Lavage (BAL) Specimens.

Zachariah P, Ryan C, Nadimpalli S, Coscia G, Kolb M, Smith H, Foca M, Saiman L, Planet PJ.

Ann Am Thorac Soc. 2018 Jun 7. doi: 10.1513/AnnalsATS.201802-146OC. [Epub ahead of print]

PMID:
29877714
15.

Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials.

Pfirrmann D, Haller N, Huber Y, Jung P, Lieb K, Gockel I, Poplawska K, Schattenberg JM, Simon P.

JMIR Res Protoc. 2018 May 22;7(5):e106. doi: 10.2196/resprot.8607.

16.

The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study.

Masekela R, Vosloo S, Venter SN, de Beer WZ, Green RJ.

BMC Pulm Med. 2018 May 22;18(1):87. doi: 10.1186/s12890-018-0632-6.

17.

IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut.

Renga G, Moretti S, Oikonomou V, Borghi M, Zelante T, Paolicelli G, Costantini C, De Zuani M, Villella VR, Raia V, Del Sordo R, Bartoli A, Baldoni M, Renauld JC, Sidoni A, Garaci E, Maiuri L, Pucillo C, Romani L.

Cell Rep. 2018 May 8;23(6):1767-1778. doi: 10.1016/j.celrep.2018.04.034.

18.

The expanding horizon of alkyl quinolone signalling and communication in polycellular interactomes.

Reen FJ, McGlacken GP, O'Gara F.

FEMS Microbiol Lett. 2018 May 1;365(9). doi: 10.1093/femsle/fny076.

PMID:
29718276
19.

Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis.

Puccetti M, Paolicelli G, Oikonomou V, De Luca A, Renga G, Borghi M, Pariano M, Stincardini C, Scaringi L, Giovagnoli S, Ricci M, Romani L, Zelante T.

Mediators Inflamm. 2018 Feb 18;2018:1601486. doi: 10.1155/2018/1601486. eCollection 2018. Review.

20.

Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.

Choo JM, Abell GCJ, Thomson R, Morgan L, Waterer G, Gordon DL, Taylor SL, Leong LEX, Wesselingh SL, Burr LD, Rogers GB.

mSphere. 2018 Apr 18;3(2). pii: e00103-18. doi: 10.1128/mSphere.00103-18. Print 2018 Apr 25.

Supplemental Content

Loading ...
Support Center